Transcriptional signatures of the BCL2 family for individualized acute myeloid leukaemia treatment

BACKGROUND: Although anti-apoptotic proteins of the B-cell lymphoma-2 (BCL2) family have been utilized as therapeutic targets in acute myeloid leukaemia (AML), their complicated regulatory networks make individualized therapy difficult. This study aimed to discover the transcriptional signatures of...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Chansub, Lee, Sungyoung, Park, Eunchae, Hong, Junshik, Shin, Dong-Yeop, Byun, Ja Min, Yun, Hongseok, Koh, Youngil, Yoon, Sung-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520894/
https://www.ncbi.nlm.nih.gov/pubmed/36171613
http://dx.doi.org/10.1186/s13073-022-01115-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520894/
https://www.ncbi.nlm.nih.gov/pubmed/36171613
http://dx.doi.org/10.1186/s13073-022-01115-w

Ejemplares similares